Is Nitric Oxide Good for Kidneys? Function and Risks

Nitric oxide is essential for healthy kidney function, but the relationship is not a simple “more is better” story. In normal amounts, this short-lived gas molecule regulates blood flow to the kidneys, controls how they filter blood, and helps manage sodium and fluid balance. Too little nitric oxide accelerates chronic kidney disease, while too much, especially during severe infections, can damage the very tissue it normally protects. The balance between these extremes determines whether nitric oxide acts as friend or foe.

How Nitric Oxide Works in a Healthy Kidney

Your kidneys filter roughly 180 liters of fluid per day, and the process depends on tightly controlled blood flow through tiny capillary networks called glomeruli. Nitric oxide is one of the most important signals that keeps this blood flow properly tuned. It acts as a vasodilator, relaxing the smooth muscle in kidney blood vessels so that filtration pressure stays in the right range.¹

A key source of nitric oxide in the kidney is a cluster of specialized cells called the macula densa, which sits at a strategic point where each nephron loops back close to its own blood supply. These cells produce nitric oxide through an enzyme variant called NOS1β, and the gas acts as a brake on a reflex known as tubuloglomerular feedback. Without that brake, the kidney would over-constrict its own blood vessels in response to changes in salt delivery, choking off filtration when it should stay open.² Animal studies show that blocking this enzyme acutely ramps up that reflex, confirming that nitric oxide is an active, moment-to-moment volume regulator.³

Beyond blood flow, nitric oxide also tells the kidney tubules to excrete more sodium and water. In practical terms, it promotes a mild diuretic and natriuretic effect, encouraging the kidney to dump salt rather than hold onto it.⁴ This happens because nitric oxide inhibits several sodium-reabsorbing pumps and exchangers along the nephron, although some studies have found that the picture in the proximal tubule is more complicated than a simple on-off switch, with opposing effects depending on the concentration and the local signaling environment.⁵

What Happens When Nitric Oxide Runs Low

If the kidney’s nitric oxide supply drops, the consequences are serious and progressive. One of the clearest demonstrations comes from research on a molecule called ADMA (asymmetric dimethylarginine), which your body produces naturally and which blocks the enzymes that make nitric oxide. In people with chronic kidney disease, ADMA accumulates in the blood because the kidneys can no longer clear it efficiently, creating a vicious cycle: damaged kidneys raise ADMA levels, ADMA suppresses nitric oxide, and the resulting nitric oxide shortage accelerates further kidney damage.⁶

A study tracking patients with mild to moderate kidney disease found that those whose ADMA levels sat above the median progressed to worse kidney function significantly faster. Their average time to a progression endpoint was about 53 months, compared with roughly 72 months for patients with lower ADMA. ADMA stood out as an independent predictor of kidney disease progression even after accounting for other risk factors.⁷

The mechanism behind this damage involves more than just blood vessel constriction. When ADMA blocks nitric oxide production, it promotes collagen buildup, activates fibrosis-driving growth factors, and causes the small blood vessels around the kidney tubules to thin out, starving surrounding tissue of oxygen.⁸ Scarring and loss of capillaries are hallmarks of chronic kidney disease, and nitric oxide deficiency appears to be an important driver of both. The connection to blood pressure also matters: the NOS1β enzyme in the macula densa protects against salt-sensitive hypertension, one of the most common pathways to kidney damage in the general population.⁹

When Too Much Nitric Oxide Causes Harm

If low nitric oxide is bad, you might assume flooding the kidneys with it would help. It does not. During severe infections like sepsis, the immune system ramps up a different nitric oxide-producing enzyme called iNOS (inducible nitric oxide synthase), which can generate enormous amounts of the gas. This surge overwhelms the kidney’s regulatory systems, disrupting blood flow within the organ and producing toxic byproducts that directly injure the tubular cells.¹⁰

The main culprit is peroxynitrite, formed when nitric oxide reacts with superoxide, a common oxygen radical. Peroxynitrite is a potent oxidant that damages proteins, lipids, and DNA. Under normal conditions, the kidney makes just enough nitric oxide and just enough superoxide that neither reaches harmful concentrations. But during inflammation or oxidative stress, superoxide production spikes, and the extra nitric oxide from iNOS combines with it to create a wave of peroxynitrite that the tissue cannot handle.¹¹ This process, sometimes called nitrosative stress, explains why blanket nitric oxide supplementation is not a wise strategy for sick kidneys. The source of the nitric oxide, the amount produced, and the local oxidative environment all matter.

The Diabetic Kidney Paradox

Diabetes creates a particularly confusing nitric oxide picture in the kidneys. In the early stages of diabetic kidney disease, nitric oxide levels actually rise. The high-glucose environment stimulates certain nitric oxide synthase enzymes, and the resulting vasodilation is thought to contribute to the hyperfiltration that characterizes early diabetic nephropathy, where the kidneys work overtime and filter too aggressively. Over time, though, this pattern reverses. Oxidative stress builds up, ADMA levels climb, and nitric oxide bioavailability drops, shifting the balance toward constriction, fibrosis, and progressive damage.¹²

This two-phase pattern is why researchers describe nitric oxide in diabetic kidney disease as paradoxical. The same molecule that drives harmful hyperfiltration early on becomes the molecule whose absence worsens scarring later. Any therapeutic strategy aimed at nitric oxide in diabetic kidneys would need to account for the stage of disease, which makes it a much harder target than it might first appear.

Inhaled Nitric Oxide During Cardiac Surgery

One setting where nitric oxide therapy has produced the most encouraging kidney-related results is cardiac surgery involving a heart-lung machine. During these operations, the machine damages red blood cells, releasing free hemoglobin into the bloodstream. Free hemoglobin scavenges nitric oxide, depleting it from the kidney’s blood vessels and contributing to the high rate of acute kidney injury seen after these procedures.

A clinical trial found that delivering nitric oxide gas through the breathing circuit during and after surgery reduced acute kidney injury from about 64% in control patients to 50% in those receiving nitric oxide.¹³ A systematic review pooling data from multiple trials found that nitric oxide therapy reduced acute kidney injury risk by about a quarter when started at the beginning of bypass.¹⁴

More recently, a randomized trial specifically focused on cardiac surgery patients who already had chronic kidney disease, a group at especially high risk for postoperative kidney injury. Acute kidney injury occurred in about 24% of those given nitric oxide, compared with 40% in the control group.¹⁵ These results are promising, though the trials remain relatively small by cardiology standards, and nitric oxide delivery during surgery requires specialized equipment and monitoring.

The mechanism behind this protection appears to involve nitric oxide neutralizing the free hemoglobin before it can strip nitric oxide from the kidney’s endothelial cells. Studies in mice show that the enzyme eNOS, which lines blood vessel walls, also plays a role by converting nitrite into nitric oxide under low-oxygen conditions, offering an additional layer of defense against ischemia-reperfusion injury.¹⁶

Dietary Nitrate and Beetroot Juice

Outside the operating room, one of the more accessible ways to support your body’s nitric oxide production is through dietary nitrate, which is abundant in beets, spinach, arugula, and other leafy greens. Bacteria on your tongue convert nitrate from food into nitrite, and your body then reduces that nitrite into nitric oxide, especially in tissues that are low in oxygen.

A pilot study in patients with chronic kidney disease tested concentrated beetroot juice as a nitrate source. Compared with a low-nitrate control drink, the beetroot juice lowered blood pressure by a clinically meaningful amount and also reduced the renal resistive index, a measure of how much resistance the kidney’s blood vessels are putting up against blood flow. The drop in resistive index suggests that the nitric oxide produced from dietary nitrate was actually reaching the kidney vasculature and relaxing it.¹⁷

This is a single small study, so it would be premature to treat beetroot juice as a kidney therapy. But the finding is consistent with the broader body of work showing that dietary nitrate lowers blood pressure in various populations, and since uncontrolled blood pressure is the leading modifiable risk factor for kidney disease progression, even modest improvements could add up over time. One caveat for people with advanced kidney disease: high-potassium foods like beets may be restricted by a nephrologist, so the approach is not universally safe without guidance.

Citrulline Versus Arginine for Boosting Nitric Oxide

Arginine is the amino acid that nitric oxide synthase uses as a raw material, which is why arginine supplements are widely marketed as nitric oxide boosters. The problem is that about 70% of orally consumed arginine gets broken down before it ever reaches the general circulation. Citrulline, a different amino acid found in watermelon, bypasses this first-pass metabolism almost entirely and is converted into arginine in the kidneys themselves. In mice, citrulline supplementation raised plasma arginine levels to roughly 214 micromoles per liter at the highest dose, compared with about 159 micromoles per liter for an equivalent dose of arginine.¹⁸

For anyone considering supplements to support nitric oxide levels, this is relevant because it suggests citrulline may be a more efficient route. However, the clinical evidence linking citrulline supplementation to specific kidney outcomes in humans is still limited. Animal pharmacokinetics do not always translate directly, and people with impaired kidney function may handle these amino acids differently. No major nephrology guideline currently recommends either supplement for kidney protection.

PDE5 Inhibitors and the Nitric Oxide Pathway

Nitric oxide does most of its work inside cells by activating an enzyme that produces cyclic GMP (cGMP), a signaling molecule that relaxes smooth muscle and inhibits inflammation. PDE5 inhibitors, the drug class that includes sildenafil and tadalafil, work by preventing the breakdown of cGMP, essentially amplifying the downstream signal that nitric oxide has already started. Research has found that these drugs show potential for treating kidney fibrosis in chronic kidney disease by keeping the protective cGMP signal active for longer.¹⁹

In a rat model of salt-induced kidney damage, tadalafil reduced collagen-rich fibrotic areas in kidney tissue and lowered the expression of a gene involved in scar formation.²⁰ These are animal findings, and the doses and durations involved may not map neatly onto human therapy. But they illustrate that the nitric oxide-cGMP pathway is a legitimate pharmaceutical target for kidney fibrosis, not just a theoretical concept. Clinical trials in people with kidney disease are still in early stages.

Aging, Sex Hormones, and Kidney Nitric Oxide

The kidney’s nitric oxide system does not stay constant over a lifetime. Aging brings changes in both the renin-angiotensin system and the nitric oxide system that leave the older kidney more vulnerable to both acute injuries and chronic progressive disease.²¹

Sex hormones appear to modulate this decline. In studies of salt-sensitive rats, ovariectomy (which removes estrogen) led to significant drops in both eNOS and iNOS protein levels in the kidney’s inner region (the medulla) and a massive increase in inflammatory immune cell infiltration. Estrogen supplementation partially or fully reversed these changes, restoring nitric oxide synthase expression and suppressing inflammatory cell buildup.²² This may help explain why premenopausal women enjoy some protection against kidney disease that erodes after menopause, though extrapolating from rats to human hormone therapy decisions requires considerably more evidence.

Nitric Oxide and Oxygen Supply in the Kidney Medulla

The innermost part of the kidney, the medulla, operates in a state of chronic near-hypoxia even under normal conditions. It consumes enormous amounts of oxygen to drive sodium reabsorption, and its blood supply is deliberately limited to prevent washing out the concentration gradient the kidney needs to produce concentrated urine. Nitric oxide helps manage this precarious oxygen balance in two ways: it dilates the blood vessels feeding the medulla, improving oxygen delivery, and it slows down mitochondrial oxygen consumption, reducing demand.²³

In hypertension, oxidative stress depletes medullary nitric oxide, tipping the oxygen balance toward hypoxia. The resulting tissue oxygen deficit can worsen tubular injury and drive fibrosis. This is also where hydrogen sulfide, another gaseous signaling molecule, enters the picture. Hydrogen sulfide and nitric oxide interact in the medulla, and emerging research suggests they work together to maintain oxygenation, though the details of that partnership are still being worked out. The broader point is that nitric oxide’s kidney effects extend beyond filtration and blood pressure into the fundamental oxygen economy of one of the body’s most metabolically demanding tissues.